D. Two (or more) of the following signs developing during, or shortly after, hallucinogen
use: 
1. Pupillary dilation.
2. Tachycardia.
3. Sweating.
4. Palpitations.
5. Blurring of vision.
6. Tremors.
7. Incoordination.
E. The signs or symptoms are not attributable to another medical condition and are not
better explained by another mental disorder, including intoxication with another sub-
stance.
Coding note:  The ICD-9-CM code is 292.89.  The ICD-10-CM code depends on whether
there is a comorbid hallucinogen use disorder. If a mild hallucinogen use disorder is co-
morbid, the ICD-10-CM code is F16.129,  and if a moderate or severe hallucinogen use
disorder is comorbid, the ICD-10-CM code is F16.229.  If there is no comorbid hallucinogen
use disorder, then the ICD-10-CM code is F16.929.
Note:  For information on Associated Features Supporting Diagnosis and Culture-Related
Diagnostic Issues, see the corresponding sections in other hallucinogen use disorder.
Diagnostic Features
Other hallucinogen intoxication reflects the c linically significant behavioral or psycholog-
ical changes that occur shortly after ingestio n of a hallucinogen. Depending on the specific
hallucinogen, the intoxication may last only minutes (e.g., for salvia) or several hours or
longer (e.g., for LSD [lysergic acid diethy lamide] or MDMA [3,4-methylenedioxymetham-
phetamine]).